(HealthDay)—Diabetes care can be improved with enhanced communication between providers and patients and improved communication between members of the primary care team, according to a study published in the January/February ...
Jan 17, 2018
0
5
(HealthDay)—Diabetes and prediabetes duration are both independently associated with the presence of coronary artery calcified plaque (CAC) and left ventricular dysfunction, according to a study published online Jan. 9 ...
Jan 12, 2018
0
17
(HealthDay)—Unstable housing is associated with an increased likelihood of diabetes-related emergency department visits and hospitalization, according to a study published online Jan. 4 in Diabetes Care.
Jan 10, 2018
0
3
When patients are diagnosed with diabetes, primary care clinicians display high levels of technical knowledge and communication skill, but initial consultations are often driven by biomedical explanations out of context from ...
Jan 9, 2018
0
1
(HealthDay)—For patients with type 1 diabetes (T1D), there is a bidirectional association between depression and severe hypoglycemia and hyperglycemia, according to a study published online Dec. 18 in Diabetes Care.
Jan 5, 2018
0
8
(HealthDay)—Decisions about diabetes care can become harder as people age, and that may be especially true for those needing hospice care.
Jan 4, 2018
0
2
(HealthDay)—Dasiglucagon is well tolerated and is associated with an early pharmacodynamic response similar to that of GlucaGen for severe hypoglycemia, according to a study published online Dec. 22 in Diabetes Care.
Jan 3, 2018
0
2
(HealthDay)—The cumulative risk of end-stage renal disease (ESRD) among patients with type 1 diabetes has declined over time in Finland, according to a study published online Dec. 20 in Diabetes Care.
Dec 27, 2017
0
4
The Centers for Disease Control have found that diabetes is more common in Appalachia than in the nation as a whole. And according to a recent needs assessment by the Diabetes Institute at the Ohio University Heritage College ...
Dec 27, 2017
0
4
(HealthDay)—The reduction in risk of cardiovascular (CV) death with empagliflozin is most mediated by changes in hematocrit and hemoglobin, according to research published online Dec. 4 in Diabetes Care.
Dec 26, 2017
0
6
